Psychopharmacology

, Volume 225, Issue 3, pp 605–612

Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial

  • Lai Kuan Lee
  • Suzana Shahar
  • Ai-Vyrn Chin
  • Noor Aini Mohd Yusoff
Original Investigation

DOI: 10.1007/s00213-012-2848-0

Cite this article as:
Lee, L.K., Shahar, S., Chin, AV. et al. Psychopharmacology (2013) 225: 605. doi:10.1007/s00213-012-2848-0

Abstract

Rationale

Epidemiological studies have suggested a beneficial effect of fish oil supplementation in halting the initial progression of Alzheimer’s disease. However, it remains unclear whether fish oil affects cognitive function in older people with mild cognitive impairment (MCI).

Objectives

This study investigated the effects of fish oil supplementation on cognitive function in elderly person with MCI.

Methods

This was a 12-month, randomised, double-blind, placebo-controlled study using fish oil supplementation with concentrated docosahexaenoic acid (DHA). Thirty six low-socioeconomic-status elderly subjects with MCI were randomly assigned to receive either concentrated DHA fish oil (n = 18) or placebo (n = 18) capsules. The changes of memory, psychomotor speed, executive function and attention, and visual-constructive skills were assessed using cognitive tests. Secondary outcomes were safety and tolerability of the DHA concentrate.

Results

The fish oil group showed significant improvement in short-term and working memory (F = 9.890; ηp2 = 0.254; p < 0.0001), immediate verbal memory (F = 3.715; ηp2 = 0.114; p < 0.05) and delayed recall capability (F = 3.986; ηp2 = 0.121; p < 0.05). The 12-month change in memory (p < 0.01) was significantly better in the fish oil group. Fish oil consumption was well tolerated, and the side effects were minimal and self-limiting.

Conclusions

This study suggested the potential role of fish oil to improve memory function in MCI subjects. Studies with larger sample sizes, longer intervention periods, different fish oil dosages and genetic determinations should be investigated before definite recommendations can be made.

Keywords

Fish oilMild cognitive impairmentDocosahexaenoic acidCognitive functionMemory

Abbreviations

AD

Alzheimer’s disease

ADAS-cog

Cognitive section of the AD Assessment Scale

ANCOVA

Analysis of covariance

CDT

Clock drawing test

DHA

Docosahexaenoic acid

EPA

Eicosapentaenoic acid

GDS

Geriatric depression scale

MCI

Mild cognitive impairment

MMSE

Mini-mental state examination

PUFAs

Polyunsaturated fatty acids

RAVLT

Rey Auditory Verbal Learning Test

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Lai Kuan Lee
    • 2
  • Suzana Shahar
    • 1
  • Ai-Vyrn Chin
    • 3
  • Noor Aini Mohd Yusoff
    • 4
  1. 1.School of Health Care Sciences, Faculty of Health SciencesUniversiti Kebangsaan MalaysiaKuala LumpurMalaysia
  2. 2.Nutrition Science Program, School of Health Care Sciences, Faculty of Health SciencesUniversiti Kebangsaan MalaysiaKuala LumpurMalaysia
  3. 3.Department of Geriatrics, Faculty of MedicineUniversiti MalayaKuala LumpurMalaysia
  4. 4.Faculty of Therapeutic SciencesMasterskill University College of Health SciencesCherasMalaysia